Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

Project Information

CARBALIVE

Grant agreement ID: 634579

DOI 10.3030/634579

Project closed

EC signature date 7 April 2015

Start date 1 May 2015

End date 31 January 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 9 579 686,54

EU contribution € 5 913 079,75

Coordinated by

UNIVERSITY COLLEGE LONDON
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Other (1)

Project website and social media accounts

Project website established allowing public access to non-confidential information about the CARBALIVE project.

Publications

Peer reviewed articles (2)

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Author(s): Agustín Albillos; Andrea de Gottardi; María Rescigno
Published in: Journal of Hepatology, Issue 1, 2020, ISSN 1600-0641
Publisher: Elsevier
DOI: 10.7892/boris.148408

Targeting the gut-liver axis in liver disease

Author(s): Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S. Bajaj, Rajiv Jalan
Published in: Journal of Hepatology, Issue 67/5, 2017, Page(s) 1084-1103, ISSN 0168-8278
Publisher: Elsevier BV
DOI: 10.1016/j.jhep.2017.05.007